Application of lipids and plasmid design for gene delivery to mammalian cells

Current Opinion in Biotechnology

Volumn 9, Issue 5, 1998, Pages 480-485

  Scherman, Daniel ^a   Bessodes, Michel ^a   Cameron, Béatrice ^a   Herscovici, Jean ^a   Hofland, Hans ^a   Pitard, Bruno ^a   Soubrier, Fabienne ^a   Wils, Pierre ^a   Crouzet, Joël ^a  

^a SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CATION; LIPID; PLASMID DNA; PLASMID VECTOR; VIRUS VECTOR;

BACTERIAL GENE; BIOCHEMISTRY; COMPLEX FORMATION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MAMMAL CELL; MOLECULAR MIMICRY; NONHUMAN; PRIORITY JOURNAL; REVIEW;

BACTERIA (MICROORGANISMS); MAMMALIA;

EID: 0032190676     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0958-1669(98)80033-5     Document Type: Article

References (59)

1. Boussif O, Lezoualc'h F, Zanta MA, Mergny M, Scherman D, Demeinex B, Behr JP. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polmyethylenimine. Proc Natl Acad Sci USA. 92:1995;7297-7301.
2. Lee RJ, Huang L. Lipidic vector system for gene transfer. Crit Rev Ther Drug Carrier Sys. 14:1997;173-206.
3. Mahato R, Takabura Y, Hashida M. Nonviral vectors for gene delivery: physicochemical and pharmakokinetic considerations. Crit Rev Ther Drug Carrier Sys. 14:1997;133-172.
4. Lasic DD. Liposomes in Gene Delivery. 1997;CRC Press, Boca Raton, NY.
5. Smith J, Zhang Y, Niven R. Toward the development of a non-viral gene therapeutic. Adv Drug Deliv Rev. 26:1997;135-150.
6. Gorman CM, Aikawa M, Fox B, Lapuz C, Michaud B, Nguyen H, Roche E, Sawa T, Wiener-Kronish JP. Efficient in vivo delivery of DNA to pulmonary cells using the novel lipid EDMPC. Gene Ther. 4:1997;983-992.
7. Lee ER, Marshall J, Siegel CS, Jiang C, Yew NS, Nichols MR, Nietupski JB, Ziegler RJ, Lane MB, Wang KX. Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung. Hum Gene Ther. 7:1996;1701-1717.
8. Byk G, Dubertret C, Escriou V, Frederic M, Jaslin G, Rangara R, Pitard B, Crouzet J, Wils P, Schwartz B, Scherman D. Synthesis, activity, and structure-activity relationship studies of novel cationic lipids for DNA transfer. J Med Chem. 41:1998;224-235.
9. Zhang G, Gurtu V, Smith TH, Nelson P, Kain SR. A cationic lipid for rapid and efficient delivery of plasmid DNA into mammalian cells. Biochem Biophys Res Commun. 236:1997;126-129.
10. Okayama R, Noji M, Nakanishi M. Cationic cholesterol with a hydroxyethylamino head group promotes significantly liposome-mediated gene transfection. FEBS Lett. 408:1997;232-234.
11. Legendre JY, Trzeciak A, Bohrmann B, Deuschle U, Kitas E, Supersaxo A. Dioleoylmelittin as a novel serum-insensitive reagent for efficient transfection of mammalian cells. Bioconjug Chem. 8:1997;57-63.
12. Liang E, Hughes J. Characterization of a pH-sensitive surfactant, dodecyl-2-(1'-imidazolyl) propionate (DIP), and preliminary studies in liposome mediated gene transfer. of special interest Biochim Biophys Acta. 1369:1998;39-50 A membrane disruption agent, dodecyl-2-(imidazolyl)propionate (DIP), was incorporated in a delivery vector and showed enhancement of transgene expression by fivefold in vitro by selectively increasing the release of endosomally encapsulated DNA.
13. Hirsch-Lerner D, Barenholz Y. Probing DNA-cationic lipid interactions with the fluorophore trimethylammonium diphenylhexatriene (TMADPH). Biochim Biophys Acta. 1370:1998;17-30.
14. Wisner ER, Aho-Sharon KL, Bennett MJ, Penn SG, Lebrilla CB, Nantz MH. A modular lymphographic magnetic resonance imaging contrast agent: contrast enhancement with DNA transfection potential. of outstanding interest J Med Chem. 40:1997;3992-3996 To investigate the possibility of studying a DNA transfection event by contrast NMR, a gadolinium-chelated liposomal contrast agent was prepared. DNA transfection in vitro confirmed the activity of the contrast agent and exemplified the potential of this system for developing new imaging and DNA delivery vehicles.
15. Blessing T, Rémy JS, Behr JP. Molecular collapse of plasmid DNA into stable virus-like particles. Proc Natl Acad Sci USA. 95:1998;1427-1431.
16. Anchordoquy J, Carpenter JF, Kroll DJ. Maintenance of transfection rates and physical characterization of lipid/DNA complexes after freeze-drying and rehydration. Arch Biochem Biophys. 348:1997;199-206.
17. Ferrari ME, Nguyen CM, Zelphati O, Tsai Y, Feigner P. Analytical methods for the characterization of cationic lipid-nucleic acid complexes. Hum Gene Ther. 9:1998;341-351.
18. Eastman SJ, Siegel C, Tousignant J, Smith AE, Cheng SH, Scheule RK. Biophysical characterization of cationic lipid: DNA complexes. Biochim Biophys Acta. 1325:1997;41-62.
19. Radler JO, Koltover I, Salditt T, Safinya CR. Structure of DNA-cationic liposome complexes: DNA intercalation in multilamellar membranes in distinct interhelical packing regimes. of outstanding interest Science. 275:1997;810-814 This paper shows that DNA associated with unilamellar liposomes of DOTAP/DOPC form multilamellar vesicles containing the DNA molecules intercalated between the lipid bilayers.
20. Lasic D, Strey H, Stuart M, Podgornik R, Frederik PM. The structure of DNA-liposomes complexes. J Am Chem Soc. 119:1997;832-833.
21. Pitard B, Aguerre O, Airiau M, Lachagès AM, Boukhnikachvili T, Byk G, Dubertret C, Herviou C, Scherman D, Mayaux JF, Crouzet J. Virus-sized self-assembling lamellar complexes between plasmid DNA and cationic micelles promote gene transfer. Proc Natl Acad Sci USA. 94:1997;14412-14417.
22. Zabner J, Fasbender AJ, Moninger T, Poellinger KA, Welsh MJ. Cellular and molecular barriers to gene transfer by a cationic lipid. J Biol Chem. 270:1995;18997-19007.
23. Matsui H, Johnson LG, Randell SH, Boucher RC. Loss of binding and entry of liposome-DNA complexes decreases transfection efficiency in differentiated airway epithelial cells. J Biol Chem. 272:1997;1117-1126.
24. El Ouahabi A, Thiry M, Pector V, Fuks R, Ruysschaert JM, Vandenbranden M. The role of endosome destabilizing activity in the gene transfer process mediated by cationic lipids. FEBS Lett. 414:1997;187-192.
25. Escriou V, Ciolina C, Lacroix F, Byk G, Scherman D, Wils P. Cationic lipid-mediated gene transfer: effect of serum on cellular uptake and intracellular fate of lipopolyamine/DNA complexes. Biochim Biophys Acta. 1368:1998;276-288.
26. Reimer DL, Kong S, Bally MB. Analysis of cationic liposome-mediated interactions of plasmid DNA with murine and human melanoma cells in vitro. J Biol Chem. 272:1997;19480-19487.
27. Yang JP, Huang L. Overcoming the inhibitory effect of serum on lipofection by increasing the charge ratio of cationic liposome to DNA. Gene Ther. 4:1997;950-960.
28. Tseng WC, Haselton FR, Giorgio TD. Transfection by cationic liposomes using simultaneous single cell measurements of plasmid delivery and transgene expression. of special interest J Biol Chem. 272:1997;25641-25647 This paper gives a detailed quantitative analysis of intracellular DNA delivery and transgene expression at the single cell level. The results show that plasmid delivery heterogeneity in a cell population is responsible for transfection heterogeneity.
29. Stegman T, Legendre JY. Gene transfer mediated by cationic lipids: lack of correlation between lipid mixing and transfection. Biochim Biophys Acta. 1325:1997;71-79.
30. Pollard H, Remy JS, Loussouarn G, Demolomble S, Behr JP, Escande D. Polyethylenimine but not cationic lipids promote transgene delivery to the nucleus in mammalian cells. J Biol Chem. 273:1998;7507-7511.
31. Labat-Moleur F, Steffan AM, Brisson C, Perron H, Feugeas O, Furstenberger P, Oberling F, Brambilla E, Behr JP. An electron microscopy study into the mechanism to gene transfer with lipopolyamines. Gene Ther. 3:1996;1010-1017.
32. Wagner JA, Gardner P. Toward cystic fibrosis gene therapy. Annu Rev Med. 48:1997;203-216.
33. Knowles MR, Noone PG, Hohneker K, Johnson LG, Boucher RC, Efthimiou J, Crawford C, Brown R, Schwartzbach C, Pearlman R. A double-blind, placebo controlled, dose ranging study to evaluate the safety and biological efficacy of the lipid-DNA complex GR213487B in the nasal epithelium of adult patients with cystic fibrosis. Hum Gene Ther. 9:1998;249-269.
34. Oudrhiri N, Vigneron JP, Peuchmaur M, Leclerc T, Lehn JM, Lehn P. Gene transfer by guanidinium-cholesterol cationic lipids into airway epithelial cells in vitro and in vivo. Proc Natl Acad Sci USA. 94:1997;1651-1656.
35. Dachs GU, Dougherty GJ, Stratford IJ, Chaplin DJ. Targeting gene therapy to cancer: a review. Oncol Res. 9:1997;313-325.
36. Rubin J, Galanis E, Pitot HC, Richardson RL, Burch PA, Charboneau JW, Reading CC, Lewis BD, Stahl S, Akporiaye ET, Harris DT. Phase I study of immunotherapy of hepatic metastases of colorectal carcinoma by direct gene transfer of an allogeneic histocompatibility antigen, HLA-B7. Gene Ther. 4:1997;419-425.
37. Hui KM, Ang PT, Huang L, Tay SK. Phase I study of immunotherapy of cutaneous metastases of human carcinoma using allogeneic and xenogeneic MHC DNA-liposome complexes. Gene Ther. 4:1997;783-790.
38. Zlokovic BV, Apuzzo ML. Cellular and molecular neurosurgery: pathways from concept to reality - part II: vector systems and delivery methodologies for gene therapy of the central nervous system. Neurosurgery. 40:1997;805-812.
39. Yang K, Clifton GL, Hayes RL. Gene therapy for central nervous system injury: the use of cationic liposomes: an invited review. J Neurotrauma. 14:1997;281-297.
40. Okamoto T, Kaneda Y, Yuzuki D, Huang SK, Chi DD, Hoon DS. Induction of antibody response to human tumor antigens by gene therapy using a fusigenic viral liposome vaccine. Gene Ther. 4:1997;969-976.
41. Asahara T, Takeshita S, Tsurumi Y, Feldman L, Isner JM. Arterial gene therapy: a molecular biological perspective for the treatment of arterial ischemia. Z Kardiol. 86:1997;65-69. (suppl 1).
42. Kaneda Y, Morishita R, Dzau VJ. Prevention of restenesosis by gene therapy. Ann NY Acad Sci. 811:1997;299-308.
43. Stephan DJ, Yang ZY, San H, Simari RD, Wheeler CJ, Felgner PL, Gordon D, Nabel GJ, Nabel EG. A new cationic liposome DNA complex enhances the efficiency of arterial gene transfer in vivo. Hum Gene Ther. 7:1996;1803-1812.
44. Nomura T, Nakamura S, Kawabata K, Yamashita F, Takakura Y, Hashida M. Intratumoral pharmacokinetics and in vivo gene expression of naked plasmid DNA and its cationic liposome complexes after direct gene transfer. Cancer Res. 57:1997;2681-2686.
45. Fasbender A, Zabner J, Chillon M, Moninger TO, Puga AP, Davidson BL, Welsh MJ. Complexes of adenovirus with polycationic polymers and cationic lipids increase the efficiency of gene transfer in vitro and in vivo. J Biol Chem. 272:1997;6479-6489.
46. Hodgson CP, Xu G, Solaiman F, Zink MA. Biosynthetic retrovectoring systems for gene therapy. J Mol Med. 75:1997;249-258.
47. Lai LW, Moeckel GW, Lien YH. Kidney-targeted liposome-mediated gene transfer in mice. Gene Ther. 4:1997;426-431.
48. Lai W, Chan DM, Erickson RP, Hsu SJ, Lien YH. Correction of renal tubular acidosis in carbonic anhydrase II-deficient mice with gene therapy. J Clin Invest. 101:1998;1320-1325.
49. McLean JW, Fox EA, Baluk P, Bolton PB, Haskell A, Pearlman R, Thurston G, Umemoto EY, McDonald DM. Organ-specific endothelial cell uptake of cationic liposome-DNA complexes in mice. Am J Physiol. 273:1997;387-404.
50. Thurston G, McLean JW, Rizen M, Baluk P, Haskell A, Murphy TJ, Hanahan D, McDonald DM. Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice. J Clin Invest. 101:1998;1401-1413.
51. Lee RJ, Huang L. Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer. J Biol Chem. 271:1996;8481-8487.
52. Hsiao M, Tse V, Carmel J, Tsai Y, Felgner PL, Haas M, Silverberg GD. Intracavitary liposome-mediated p53 gene transfer into glioblastoma with endogenous wild-type p53 in vivo results in tumor suppression and long-term survival. Biochem Biophys Res Commun. 233:1997;359-364.
53. Filion MC, Phillips NC. Anti-inflammatory activity of cationic lipids. Br J Pharmacol. 12:1997;551-557.
54. Roman M, Martin-Orozco E, Goodman JS, Nguyen MD, Sato Y, Ronaghy A, Kornbluth RS, Richman DD, Carson DA, Raz E. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nat Med. 3:1997;849-854.
55. Norman JA, Hobart P, Manthorpe M, Felgner P, Wheeler C. Development of improved vectors for DNA-based immunization and other gene therapy applications. Vaccine. 15:1997;801-813.
56. Williams SG, Cranenburgh RM, Weiss AME, Wrighton CJ, Sherratt DJ, Hanak JA. Repressor titration: a novel system for selection and stable maintenance of recombinant plasmids. Nucleic Acids Res. 26:1998;2120-2124.
57. Soubrier F, Cameron B, Jung G, Dubertret C, Schwartz B, Naimi S, Caillaud JM, Rouy D, Castel-Barthe MN, Mahfoudi A, et al. pCOR are safe and effective plasmid DNA vehicles for non-viral gene therapy and DNA vaccination [abstract]. Fifth meeting of EWGT. 1997;. Nov 21-23; Milan.
58. Darquet AM, Cameron B, Wils P, Scherman D, Crouzet J. A new DNA vehicle for nonviral gene delivery: supercoiled minicircle. Gene Ther. 4:1997;1341-1349.
59. Sebestyen MG, Ludtke JJ, Bassik MC, Zhang G, Budker V, Lukhtanov EA, Hagstrom JE, Wolff JA. DNA vector chemistry: the covalent attachment of signal peptides to plasmid DNA. Nat Biotechnol. 16:1998;80-85.